Check Cap Ltd (CHEK) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Check Cap Ltd (CHEK) has a cash flow conversion efficiency ratio of 0.000x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-536.00) by net assets ($-1.45 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Check Cap Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how Check Cap Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Check Cap Ltd carry for a breakdown of total debt and financial obligations.
Check Cap Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Check Cap Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
LABORATORIO FARMAC.ERFO
F:RK7
|
N/A |
|
CMO Public Company Limited
BK:CMO
|
0.171x |
|
NeuroMetrix Inc
NASDAQ:NURO
|
-0.132x |
|
Adelong Gold Ltd
AU:ADG
|
-0.066x |
|
Kumpulan Jetson Bhd
KLSE:9083
|
0.044x |
|
Godolphin Resources Ltd
AU:GRL
|
-0.143x |
|
Jupiter Fund Management Plc
LSE:JUP
|
0.024x |
|
STO Co. Ltd
KQ:098660
|
0.024x |
Annual Cash Flow Conversion Efficiency for Check Cap Ltd (2012–2025)
The table below shows the annual cash flow conversion efficiency of Check Cap Ltd from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see CHEK stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $-1.45 Million | $-8.00K | 0.006x | -99.90% |
| 2024-12-31 | $-1.45 Million | $-8.00 Million | 5.520x | +871.22% |
| 2023-12-31 | $23.69 Million | $-16.95 Million | -0.716x | -58.06% |
| 2022-12-31 | $41.31 Million | $-18.71 Million | -0.453x | -41.13% |
| 2021-12-31 | $50.69 Million | $-16.26 Million | -0.321x | +59.93% |
| 2020-12-31 | $16.38 Million | $-13.11 Million | -0.801x | +61.14% |
| 2019-12-31 | $6.23 Million | $-12.84 Million | -2.060x | -167.53% |
| 2018-12-31 | $13.03 Million | $-10.03 Million | -0.770x | +50.30% |
| 2017-12-31 | $5.91 Million | $-9.15 Million | -1.550x | -103.53% |
| 2016-12-31 | $10.41 Million | $-7.92 Million | -0.761x | -11.60% |
| 2015-12-31 | $12.65 Million | $-8.63 Million | -0.682x | +66.55% |
| 2014-12-31 | $2.23 Million | $-4.54 Million | -2.039x | +33.59% |
| 2013-12-31 | $1.19 Million | $-3.66 Million | -3.071x | -278.58% |
| 2012-12-31 | $5.13 Million | $-4.16 Million | -0.811x | -- |
About Check Cap Ltd
Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology products. The company was incorporated in 2004 and is based in Isfiya, Israel.